Audited Financial Results for the Quarter and Financial Year ended March 31, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Everest Organics reported a sharp deterioration in FY25 results. Total income fell to Rs. 16,016.59 lakhs from Rs. 19,412.74 lakhs in FY24, a decline of around 17%. The company swung to a net loss of Rs. 129.03 lakhs for the year, compared to a profit of Rs. 291.30 lakhs in the previous year, translating to a loss per share of Rs. 2.97. Operating cash flow also turned negative at minus Rs. 537.69 lakhs against positive Rs. 1,607.32 lakhs last year. The statutory auditors issued a qualified opinion, flagging that the company is producing beyond approved TSPCB capacity limits without the required consents, a recurring qualification for four years that could affect its going concern status. The company raised Rs. 2,700 lakhs through a preferential share issue and warrants during Q4 to fund a new production block and working capital needs.
Shareholders should note the swing to losses, shrinking top line, and a qualified audit report with a going concern caveat — all of which are negative signals for the stock. The fresh equity dilution from the preferential issue will also reduce per-share value for existing holders.